COVID 19 Medications

TRHC Fills the Information Gap on COVID-19 Proposed Therapies with a New Digital Resource

Moorestown, NJ, May 19, 2020 – Tabula Rasa HealthCare® Corporation (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, today published on the web the TRHC COVID-19 Treatment and Therapy Digital Resource. Developed by TRHC’s Precision Pharmacotherapy Research & Development Institute, the resource provides a comprehensive analysis and clinical reviews of potential treatments and therapies for COVID-19. “There are knowledge gaps surrounding the proposed treatments for COVID-19,” said TRHC Chairman and CEO... Read More

Free Webinar: Important Medication Safety Considerations for COVID-19 Treatment

Join Tabula Rasa HealthCare and Strategic Solutions Network on Thursday, May 7, 2020, at 1 p.m. EDT for a free webinar. Richard O. Schamp, MD, TRHC Chief Medical Officer, Veronique Michaud, BPharm, PhD, TRHC Chief Operating Officer, and Jacques Turgeon, BPharm, PhD, Chief Scientific Officer, will discuss the importance of understanding the risks associated with COVID-19 treatment – especially for vulnerable individuals with several chronic diseases who take multiple medications.   To register for the... Read More